| UnitedHealth Group Inc. (UNH) | $447.57B | 2.7% | 25.8× | $360.32B |
| McKesson Corp. (MCK) | $403.43B | 1.2% | 26.9× | $117.15B |
| CVS Health Corp. (CVS) | $402.07B | 0.4% | 24.3× | $118.13B |
| Cencora, Inc. (COR) | $321.33B | 0.5% | 25.3× | $65.06B |
| Cigna Group (CI) | $274.90B | 2.2% | 12.5× | $79.88B |
| Cardinal Health Inc. (CAH) | $254.25B | 0.7% | 35.1× | $58.83B |
| Elevance Health, Inc. (ELV) | $199.13B | 2.8% | 19.0× | $92.88B |
| Centene Corp. (CNC) | $174.58B | -3.8% | — | $34.16B |
| Humana Inc. (HUM) | $129.66B | 0.9% | 39.1× | $49.61B |
| Johnson & Johnson (JNJ) | $94.19B | 28.5% | 38.8× | $615.87B |
| HCA Healthcare, Inc. (HCA) | $75.60B | 9.0% | 15.4× | $99.34B |
| Eli Lilly & Co. (LLY) | $65.18B | 31.7% | 42.2× | $1.12T |
| Merck & Co., Inc. (MRK) | $65.01B | 28.1% | 115.8× | $360.08B |
| Pfizer Inc. (PFE) | $62.58B | 12.4% | 38.9× | $168.60B |
| AbbVie Inc. (ABBV) | $61.16B | 6.9% | 80.6× | $504.37B |
| Bristol Myers Squibb Co. (BMY) | $48.19B | 14.6% | 13.2× | $122.05B |
| Molina Healthcare, Inc. (MOH) | $45.43B | 1.0% | — | $10.82B |
| Thermo Fisher Scientific Inc. (TMO) | $44.56B | 15.0% | 37.1× | $255.13B |
| Abbott Laboratories (ABT) | $44.33B | 14.7% | 33.8× | $181.50B |
| Amgen Inc. (AMGN) | $36.75B | 21.0% | 26.9× | $233.82B |
| Medtronic plc (MDT) | $36.36B | 13.2% | 23.3× | $121.20B |
| Gilead Sciences, Inc. (GILD) | $29.44B | 28.9% | — | $193.67B |
| Medline Inc. (MDLN) | $28.43B | 4.1% | 89.9× | $48.38B |
| Stryker Corp. (SYK) | $25.12B | 12.9% | 30.5× | $113.02B |
| 3M Co. (MMM) | $24.95B | 13.0% | 29.3× | $84.97B |
| Danaher Corp. (DHR) | $24.57B | 14.7% | 40.8× | $161.01B |
| Becton Dickinson & Co. (BDX) | $21.84B | 7.7% | 44.6× | $52.23B |
| Tenet Healthcare Corp. (THC) | $21.31B | 11.1% | 10.8× | $22.15B |
| GE HealthCare Technologies Inc. (GEHC) | $20.63B | 10.1% | 16.0× | $31.42B |
| Boston Scientific Corp. (BSX) | $20.07B | 14.4% | 18.0× | $64.33B |
| Universal Health Services Inc. (UHS) | $17.36B | 8.6% | 7.4× | $10.55B |
| Teva Pharmaceutical Industries Ltd. (TEVA) | $17.26B | 8.2% | 70.3× | $48.40B |
| Iqvia Holdings Inc. (IQV) | $16.31B | 8.3% | 33.2× | $43.93B |
| Regeneron Pharmaceuticals, Inc. (REGN) | $14.34B | 31.4% | 19.6× | $81.41B |
| Viatris Inc (VTRS) | $14.25B | -24.7% | — | $20.93B |
| Labcorp Holdings Inc. (LH) | $13.95B | 6.3% | 26.3× | $25.79B |
| Davita Inc. (DVA) | $13.64B | 5.5% | 15.4× | $11.60B |
| Henry Schein Inc. (HSIC) | $13.18B | 3.0% | 24.8× | $9.54B |
| BrightSpring Health Services, Inc. (BTSG) | $12.91B | 1.5% | 55.8× | $12.47B |
| Community Health Systems Inc. (CYH) | $12.48B | 4.1% | 1.6× | $411.7M |
| Vertex Pharmaceuticals Inc. (VRTX) | $12.00B | 32.9% | 28.9× | $126.66B |
| Oscar Health, Inc. (OSCR) | $11.70B | -3.8% | — | $10.43B |
| Baxter International Inc. (BAX) | $11.24B | -8.5% | — | $12.81B |
| Quest Diagnostics Inc. (DGX) | $11.04B | 9.0% | 24.6× | $25.94B |
| Bausch Health Companies Inc. (BHC) | $10.27B | 1.5% | — | $2.22B |
| Intuitive Surgical Inc. (ISRG) | $10.06B | 28.4% | 48.9× | $150.74B |
| Biogen Inc. (BIIB) | $9.89B | 13.1% | 41.3× | $34.37B |
| Zoetis Inc. (ZTS) | $9.47B | 28.2% | 13.1× | $32.80B |
| Rockwell Automation, Inc. (ROK) | $8.34B | 10.4% | 39.9× | $47.43B |
| Solventum Corp (SOLV) | $8.32B | 18.7% | 10.6× | $14.96B |
| Icon PLC (ICLR) | $8.25B | 2.8% | 177.9× | $13.04B |
| Zimmer Biomet Holdings, Inc. (ZBH) | $8.23B | 8.6% | 23.0× | $18.00B |
| Agilent Technologies, Inc. (A) | $6.95B | 18.8% | 34.1× | $48.77B |
| Avantor, Inc. (AVTR) | $6.55B | -8.1% | — | $10.48B |
| Ardent Health, Inc. (ARDT) | $6.32B | 2.1% | 21.4× | $1.63B |
| Organon & Co. (OGN) | $6.22B | 3.0% | 17.6× | $3.61B |
| Edwards Lifesciences Corp (EW) | $6.07B | 17.7% | 51.5× | $49.92B |
| STERIS plc (STE) | $5.94B | 13.2% | 27.2× | $21.71B |
| Encompass Health Corp (EHC) | $5.94B | 9.5% | 21.2× | $12.49B |
| agilon health, inc. (AGL) | $5.93B | -6.6% | — | $1.44B |
| Resmed Inc. (RMD) | $5.65B | 26.9% | 22.9× | $33.61B |
| Option Care Health, Inc. (OPCH) | $5.65B | 3.7% | 23.6× | $4.66B |
| Select Medical Holdings Corp. (SEM) | $5.45B | 2.7% | 15.4× | $2.05B |
| BeOne Medicines Ltd. (ONC) | $5.34B | 5.4% | 66.0× | $41.99B |
| PACS Group, Inc. (PACS) | $5.29B | 3.6% | 26.3× | $7.12B |
| Incyte Corp. (INCY) | $5.14B | 25.0% | 14.4× | $22.92B |
| Bausch & Lomb Corp (BLCO) | $5.10B | -7.1% | — | $5.74B |
| Herbalife Ltd. (HLF) | $5.04B | 4.5% | 9.0× | $1.47B |
| Ensign Group, Inc. (ENSG) | $5.03B | 6.8% | 27.6× | $10.25B |
| Elanco Animal Health Inc (ELAN) | $4.71B | -4.9% | — | $11.26B |
| Dexcom Inc. (DXCM) | $4.66B | 17.9% | 34.1× | $32.47B |
| Illumina, Inc. (ILMN) | $4.34B | 19.6% | 49.0× | $39.64B |
| Idexx Laboratories Inc. (IDXX) | $4.30B | 24.6% | 39.4× | $44.15B |
| Jazz Pharmaceuticals plc (JAZZ) | $4.27B | -8.3% | — | $13.61B |
| PERRIGO Co plc (PRGO) | $4.25B | -33.5% | — | $2.28B |
| Cooper Companies, Inc. (COO) | $4.09B | 9.2% | 18.7× | $10.44B |
| Align Technology Inc. (ALGN) | $4.03B | 10.2% | 24.9× | $10.26B |
| Mettler Toledo International Inc. (MTD) | $4.03B | 21.6% | 36.6× | $32.51B |
| Charles River Laboratories International, Inc. (CRL) | $4.02B | -3.6% | — | $14.55B |
| Alignment Healthcare, Inc. (ALHC) | $3.95B | -0.0% | — | $1.71B |
| Alnylam Pharmaceuticals, Inc. (ALNY) | $3.71B | 8.4% | 39.1× | $31.02B |
| DENTSPLY SIRONA Inc. (XRAY) | $3.68B | -16.3% | — | $1.70B |
| Trimble Inc. (TRMB) | $3.59B | 11.8% | — | $14.22B |
| Bruker Corp. (BRKR) | $3.44B | -0.3% | — | $8.56B |
| Acadia Healthcare Company, Inc. (ACHC) | $3.31B | -33.3% | — | $2.80B |
| Surgery Partners, Inc. (SGRY) | $3.31B | -2.4% | — | $1.93B |
| AdaptHealth Corp. (AHCO) | $3.24B | -2.2% | — | $844.5M |
| Biomarin Pharmaceutical Inc. (BMRN) | $3.22B | 10.8% | 149.0× | $10.67B |
| Brookdale Senior Living Inc. (BKD) | $3.19B | -8.2% | — | $2.41B |
| UNITED THERAPEUTICS Corp (UTHR) | $3.18B | 41.9% | 19.1× | $22.87B |
| Waters Corp. (WAT) | $3.17B | 20.3% | 110.6× | $42.90B |
| MiniMed Group, Inc. (MMED) | $3.10B | -10.7% | — | $5.06B |
| West Pharmaceutical Services Inc. (WST) | $3.07B | 16.1% | 49.4× | $27.03B |
| Amneal Pharmaceuticals, Inc. (AMRX) | $3.02B | 2.4% | 38.6× | $6.58B |
| Globus Medical Inc. (GMED) | $2.94B | 18.3% | 19.6× | $10.25B |
| Neurocrine Biosciences Inc. (NBIX) | $2.86B | 16.7% | 19.8× | $13.92B |
| Revvity, Inc. (RVTY) | $2.86B | 8.4% | 73.8× | $17.20B |
| Accendra Health Inc. (ACH) | $2.76B | -39.8% | — | $30.0M |
| QuidelOrtho Corp (QDEL) | $2.73B | -41.5% | — | $953.9M |
| Fortrea Holdings Inc. (FTRE) | $2.72B | -36.2% | — | $2.03B |
| Envista Holdings Corp (NVST) | $2.72B | 1.7% | 39.2× | $3.77B |
| Insulet Corp. (PODD) | $2.71B | 9.1% | 26.4× | $9.79B |
| Bio-Rad Laboratories, Inc. (BIO) | $2.58B | 29.4% | 46.1× | $9.73B |
| Medpace Holdings, Inc. (MEDP) | $2.53B | 17.8% | 35.8× | $17.55B |
| Chemed Corp. (CHE) | $2.53B | 10.5% | 25.8× | $6.71B |
| Teladoc Health, Inc. (TDOC) | $2.53B | -7.9% | — | $1.05B |
| Aveanna Healthcare Holdings, Inc. (AVAH) | $2.43B | 9.2% | 9.7× | $2.70B |
| Royalty Pharma plc (RPRX) | $2.38B | 32.4% | 32.4× | $35.22B |
| Hims & Hers Health, Inc. (HIMS) | $2.35B | 5.5% | — | $6.93B |
| Exelixis, Inc. (EXEL) | $2.32B | 33.7% | 18.8× | $15.11B |
| Natera, Inc. (NTRA) | $2.31B | -9.0% | — | $56.71B |
| Enovis CORP (ENOV) | $2.25B | -52.7% | — | $1.07B |
| Icu Medical Inc. (ICUI) | $2.23B | 0.0% | 137.1× | $4.18B |
| Sarepta Therapeutics, Inc. (SRPT) | $2.20B | -32.5% | — | $1.89B |
| Concentra Group Holdings Parent, Inc. (CON) | $2.16B | 7.7% | 24.2× | $4.99B |
| Privia Health Group, Inc. (PRVA) | $2.12B | 1.1% | 99.3× | $2.66B |
| Qiagen N.V. (QGEN) | $2.09B | 20.3% | 23.0× | $9.37B |
| RadNet, Inc. (RDNT) | $2.04B | -0.9% | — | $5.58B |
| Teleflex Inc. (TFX) | $1.99B | -45.4% | — | $5.30B |
| National Vision Holdings, Inc. (EYE) | $1.99B | 1.5% | 27.6× | $1.40B |
| Moderna, Inc. (MRNA) | $1.94B | — | — | $87.04B |
| Clover Health Investments, Corp. (CLOV) | $1.92B | -4.4% | — | $2.55B |
| Pediatrix Medical Group, Inc. (MD) | $1.91B | 8.6% | 13.1× | $2.22B |
| MSA Safety Inc (MSA) | $1.87B | 14.9% | 22.3× | $6.91B |
| Integer Holdings Corp (ITGR) | $1.85B | 5.5% | 34.6× | $4.31B |
| Healthcare Services Group Inc. (HCSG) | $1.84B | 3.2% | 12.4× | $1.45B |
| Ptc Therapeutics, Inc. (PTCT) | $1.73B | 39.4% | — | $5.40B |
| Integra Lifesciences Holdings Corp. (IART) | $1.64B | -31.6% | — | $1.03B |
| Lantheus Holdings, Inc. (LNTH) | $1.54B | 15.2% | 24.1× | $6.51B |
| Masimo Corp. (MASI) | $1.53B | -9.9% | — | — |
| Phibro Animal Health Corp. (PAHC) | $1.52B | 6.6% | 15.4× | $1.49B |
| Merit Medical Systems Inc. (MMSI) | $1.52B | 8.5% | 36.7× | $5.33B |
| Nu Skin Enterprises, Inc. (NUS) | $1.49B | 10.8% | — | $250.2M |
| Alkermes plc. (ALKS) | $1.48B | 16.4% | 105.6× | $6.56B |
| National Healthcare Corp. (NHC) | $1.47B | 8.2% | 27.3× | $3.80B |
| P3 Health Partners Inc. (PIII) | $1.46B | -10.1% | — | $821.3M |
| Trupanion, Inc. (TRUP) | $1.44B | 1.4% | 49.2× | $1.14B |
| LifeStance Health Group, Inc. (LFST) | $1.42B | 0.7% | 90.3× | $4.46B |
| Addus HomeCare Corp (ADUS) | $1.42B | 6.7% | 20.0× | $2.18B |
| Penumbra Inc (PEN) | $1.40B | 12.7% | 78.8× | $12.64B |
| Halozyme Therapeutics, Inc. (HALO) | $1.40B | 22.7% | 35.6× | $13.83B |
| LivaNova PLC (LIVN) | $1.39B | -17.5% | — | $4.26B |
| CONMED Corp (CNMD) | $1.37B | 3.4% | 25.9× | $1.41B |
| Haemonetics Corp. (HAE) | $1.33B | 7.3% | 57.1× | $5.38B |
| Progyny, Inc. (PGNY) | $1.29B | 4.5% | 29.2× | $2.06B |
| Curaleaf Holdings, Inc. (CURLF) | $1.27B | -18.2% | — | $2.22B |
| Indivior Pharmaceuticals, Inc. (INDV) | $1.24B | 16.9% | 11.6× | $3.83B |
| Nasus Pharma Ltd (NSRX) | $1.24B | -0.5% | — | $37.2M |
| BIO-TECHNE Corp (TECH) | $1.22B | 15.0% | 62.5× | $11.36B |
| Trulieve Cannabis Corp. (TRLV) | $1.18B | -9.9% | — | $1.95B |
| Sotera Health Co (SHC) | $1.16B | 6.7% | 31.7× | $5.15B |
| Novavax Inc. (NVAX) | $1.12B | 39.2% | — | $1.86B |
| Prestige Consumer Healthcare Inc. (PBH) | $1.09B | 17.5% | 14.0× | $2.36B |
| Embecta Corp. (EMBC) | $1.08B | 8.8% | 4.3× | $355.3M |
| Acadia Pharmaceuticals Inc. (ACAD) | $1.07B | 36.5% | 8.4× | $3.40B |
| Tandem Diabetes Care Inc. (TNDM) | $1.01B | -20.2% | — | $1.12B |
| Onto Innovation Inc. (ONTO) | $1.01B | 13.6% | 110.7× | $14.45B |
| InnovAge Holding Corp. (INNV) | $989.7M | -0.3% | — | $1.24B |
| Guardant Health, Inc. (GH) | $982.0M | -42.4% | — | $21.28B |
| Madrigal Pharmaceuticals, Inc. (MDGL) | $958.4M | -30.1% | — | $10.90B |
| Pennant Group, Inc. (PNTG) | $947.7M | 3.1% | 43.7× | $1.39B |
| Ionis Pharmaceuticals Inc. (IONS) | $943.7M | -40.4% | — | $7.52B |
| Mirion Technologies, Inc. (MIR) | $925.4M | 3.1% | 182.4× | $4.09B |
| Usana Health Sciences Inc. (USNA) | $925.3M | 1.2% | — | $276.2M |
| Tilray Brands, Inc. (TLRY) | $915.5M | -13.3% | — | $523.2M |
| Inspire Medical Systems, Inc. (INSP) | $912.0M | 15.9% | 15.2× | $1.99B |
| Ani Pharmaceuticals Inc. (ANIP) | $883.4M | 8.9% | 15.3× | $1.63B |
| Biocryst Pharmaceuticals Inc. (BCRX) | $874.8M | 30.2% | — | $2.06B |
| Warby Parker Inc. (WRBY) | $871.9M | 0.2% | 442.0× | $3.28B |
| Neogen Corp. (NEOG) | $870.4M | -0.9% | — | $2.59B |
| Harmony Biosciences Holdings, Inc. (HRMY) | $868.5M | 18.3% | 13.0× | $2.35B |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $829.4M | -0.2% | — | $8.58B |
| Myriad Genetics Inc. (MYGN) | $824.5M | -44.4% | — | $412.2M |
| Orthofix Medical Inc. (OFIX) | $822.3M | -11.2% | — | $370.7M |
| Caris Life Sciences, Inc. (CAI) | $812.0M | -8.4% | — | $8.64B |
| U S Physical Therapy Inc. (USPH) | $781.0M | 5.1% | 477.4× | $1.28B |
| Collegium Pharmaceutical, Inc. (COLL) | $780.6M | 8.1% | 18.3× | $755.0M |
| Alphatec Holdings, Inc. (ATEC) | $764.2M | -18.8% | — | $1.69B |
| Corcept Therapeutics Inc. (CORT) | $761.4M | 13.1% | 244.8× | $11.91B |
| iRhythm Holdings, Inc. (IRTC) | $747.1M | -6.0% | — | $3.52B |
| Emergent BioSolutions Inc. (EBS) | $742.9M | 7.1% | — | $362.0M |
| Repligen Corp. (RGEN) | $738.3M | 6.6% | 238.2× | $11.04B |
| Pacira BioSciences, Inc. (PCRX) | $726.4M | 1.0% | 103.7× | $1.45B |
| Amphastar Pharmaceuticals, Inc. (AMPH) | $719.9M | 13.6% | 15.4× | $1.11B |
| Supernus Pharmaceuticals, Inc. (SUPN) | $719.0M | -5.4% | — | $2.48B |
| Avanos Medical, Inc. (AVNS) | $701.2M | -10.4% | — | $1.17B |
| Kiniksa Pharmaceuticals International, plc (KNSA) | $677.6M | 8.7% | 79.3× | $6.13B |
| Ultragenyx Pharmaceutical Inc. (RARE) | $673.0M | -85.4% | — | $1.53B |
| Cresco Labs Inc. (CRLBF) | $655.8M | -20.6% | — | $238.4M |
| NovoCure Ltd (NVCR) | $655.4M | -20.8% | — | $1.70B |
| 10x Genomics, Inc. (TXG) | $642.8M | -6.8% | — | $9.35B |
| Axsome Therapeutics, Inc. (AXSM) | $638.5M | -28.7% | — | $8.47B |
| Tg Therapeutics, Inc. (TGTX) | $616.3M | 72.6% | 20.1× | $8.48B |
| Cadre Holdings, Inc. (CDRE) | $610.3M | 7.2% | 30.3× | $1.05B |
| Opko Health, Inc. (OPK) | $606.9M | -37.2% | — | $1.03B |
| INSMED Inc (INSM) | $606.4M | — | — | $21.02B |
| TransMedics Group, Inc. (TMDX) | $605.5M | 31.4% | 20.2× | $2.70B |
| Ufp Technologies Inc. (UFPT) | $602.8M | 11.3% | 31.9× | $2.29B |
| Catalyst Pharmaceuticals, Inc. (CPRX) | $589.0M | 36.4% | 18.2× | $3.85B |
| Bioventus Inc. (BVS) | $568.1M | 4.0% | 17.4× | $926.2M |
| Organogenesis Holdings Inc. (ORGO) | $564.2M | 6.6% | — | $158.3M |
| HUTCHMED (China) Ltd (HCM) | $548.5M | 83.3% | 141.0× | $2.45B |
| AtriCure, Inc. (ATRC) | $534.5M | -2.1% | — | $2.85B |
| Mirum Pharmaceuticals, Inc. (MIRM) | $521.3M | -4.5% | — | $5.59B |
| Veracyte, Inc. (VCYT) | $517.1M | 12.8% | 31.4× | $3.54B |
| Inotiv, Inc. (NOTVQ) | $513.0M | -13.4% | — | $390,419 |
| Adma Biologics, Inc. (ADMA) | $510.2M | 28.8% | 14.7× | $2.40B |
| GLAUKOS Corp (GKOS) | $507.4M | -37.0% | — | $9.91B |
| Starling Oncology, Inc. (STLN) | $502.7M | -12.1% | — | $705.3M |
| BridgeBio Pharma, Inc. (BBIO) | $502.1M | — | — | $12.98B |
| Ascend Wellness Holdings, Inc. (AAWH) | $500.6M | -23.6% | — | $82.3M |
| Travere Therapeutics, Inc. (TVTX) | $490.7M | -5.2% | — | $4.90B |
| Natures Sunshine Products Inc. (NATR) | $480.1M | 4.1% | 12.6× | $223.6M |
| Ayr Wellness Inc. (AYRWF) | $463.6M | -77.5% | — | $432,062 |
| Zai Lab Ltd (ZLAB) | $457.2M | -38.4% | — | $2.59B |
| Tarsus Pharmaceuticals, Inc. (TARS) | $451.4M | -14.7% | — | $3.48B |
| Artivion, Inc. (AORT) | $441.3M | 2.2% | — | $1.07B |
| GeneDx Holdings Corp. (WGS) | $427.5M | -4.9% | — | $1.90B |
| Mimedx Group, Inc. (MDXG) | $418.6M | 11.6% | 120.8× | $704.9M |
| Innoviva, Inc. (INVA) | $411.3M | 65.9% | 5.0× | $1.55B |
| Ardelyx, Inc. (ARDX) | $407.3M | -15.1% | — | $833.9M |
| Esperion Therapeutics, Inc. (ESPR) | $403.1M | -5.6% | — | $819.5M |
| Accuray Inc. (ARAY) | $401.9M | -12.2% | — | $26.1M |
| Immunocore Holdings plc (IMCR) | $400.0M | -8.9% | — | $1.50B |
| Krystal Biotech, Inc. (KRYS) | $389.1M | 52.6% | 41.6× | $9.83B |
| Sinovac Biotech Ltd. (SVA) | $386.0M | -51.5% | — | — |
| Sonida Senior Living, Inc. (SNDA) | $381.1M | -18.6% | — | $1.74B |
| CareDx, Inc. (CDNA) | $379.8M | -5.6% | — | $3.29B |
| Twist Bioscience Corp (TWST) | $376.6M | -20.6% | — | $10.07B |
| Arcutis Biotherapeutics, Inc. (ARQT) | $372.1M | -4.3% | — | $3.30B |
| InMode Ltd. (INMD) | $370.5M | 25.3% | 11.8× | $822.9M |
| Mannkind Corp. (MNKD) | $349.0M | 1.7% | — | $1.01B |
| Castle Biosciences Inc. (CSTL) | $344.2M | -7.0% | — | $1.00B |
| Tactile Systems Technology Inc. (TCMD) | $329.5M | 5.8% | 20.9× | $512.4M |
| Fulgent Genetics, Inc. (FLGT) | $322.7M | -18.8% | — | $590.8M |
| DocGo Inc. (DCGO) | $322.2M | -56.6% | — | $33.5M |
| Angiodynamics Inc. (ANGO) | $320.2M | -11.5% | — | $487.0M |
| CorMedix Inc. (CRMD) | $311.7M | 52.3% | 3.6× | $581.5M |
| PROCEPT BioRobotics Corp (PRCT) | $308.1M | -31.0% | — | $1.11B |
| BillionToOne, Inc. (BLLN) | $305.1M | 2.4% | 143.1× | $4.46B |
| SkinHealth Systems Inc. (SKIN) | $300.8M | -3.2% | — | $68.3M |
| Evolus, Inc. (EOLS) | $297.2M | -17.4% | — | $511.9M |
| Ironwood Pharmaceuticals Inc. (IRWD) | $296.2M | 8.1% | 4.9× | $621.3M |
| Inogen Inc (INGN) | $295.3M | -7.7% | — | $170.4M |
| Rigel Pharmaceuticals Inc. (RIGL) | $294.3M | — | 2.9× | $911.8M |
| Xeris Biopharma Holdings, Inc. (XERS) | $291.8M | 0.2% | — | $1.91B |
| Aurinia Pharmaceuticals Inc. (AUPH) | $283.1M | — | 7.2× | $2.20B |
| Adaptive Biotechnologies Corp (ADPT) | $277.0M | -21.5% | — | $3.83B |
| Vericel Corp (VCEL) | $276.3M | 6.0% | 85.6× | $2.06B |
| Harrow, Inc. (HROW) | $272.3M | -1.9% | — | $1.09B |
| Viemed Healthcare, Inc. (VMD) | $270.3M | 5.5% | 26.9× | $369.1M |
| Vireo Growth Inc. (VREOF) | $268.8M | -25.3% | — | $466.7M |
| Ligand Pharmaceuticals Inc. (LGND) | $268.1M | 46.4% | 31.1× | $5.88B |
| Iovance Biotherapeutics, Inc. (IOVA) | $263.5M | — | — | $6.60B |
| Jushi Holdings Inc. (JUSH) | $262.9M | -26.1% | — | $109.5M |
| Arvinas, Inc. (ARVN) | $262.6M | -30.8% | — | $449.7M |
| Omada Health, Inc. (OMDA) | $260.2M | -4.9% | — | $1.12B |
| Schrodinger, Inc. (SDGR) | $255.9M | -40.4% | — | $1.94B |
| Lemaitre Vascular Inc. (LMAT) | $249.6M | 23.1% | 28.6× | $1.89B |
| Arcus Biosciences, Inc. (RCUS) | $247.0M | — | — | $2.83B |
| Keros Therapeutics, Inc. (KROS) | $243.9M | 35.7% | — | $219.1M |
| Staar Surgical Co. (STAA) | $239.4M | -33.6% | — | $1.10B |
| Vaxart, Inc. (VXRT) | $237.3M | 6.9% | 2.7× | $110.9M |
| Orthopediatrics Corp. (KIDS) | $236.3M | -16.8% | — | $580.9M |
| Akebia Therapeutics, Inc. (AKBA) | $236.2M | -2.3% | — | $185.7M |
| Anaptysbio, Inc. (ANAB) | $234.6M | -5.6% | — | $1.39B |
| Cerus Corp. (CERS) | $233.8M | -6.7% | — | $463.5M |
| Talkspace, Inc. (TALK) | $228.9M | 3.4% | 131.3× | $870.6M |
| Puma Biotechnology, Inc. (PBYI) | $228.4M | 13.6% | 20.0× | $526.5M |
| Axogen, Inc. (AXGN) | $225.2M | -7.0% | — | $2.06B |
| IDEAYA Biosciences, Inc. (IDYA) | $218.7M | -52.0% | — | $3.27B |
| Vanda Pharmaceuticals Inc. (VNDA) | $216.1M | — | — | $243.7M |
| Amarin Corp. Plc\uk (AMRN) | $213.6M | -18.2% | — | $244.4M |
| Treace Medical Concepts, Inc. (TMCI) | $212.7M | -27.7% | — | $251.7M |
| Establishment Labs Holdings Inc. (ESTA) | $211.1M | -24.2% | — | $1.83B |
| Cytek Biosciences, Inc. (CTKB) | $201.5M | -33.0% | — | $701.3M |
| SI-BONE, Inc. (SIBN) | $200.9M | -9.4% | — | $882.0M |
| Strata Critical Medical, Inc. (SRTA) | $197.1M | 21.0% | 9.1× | $401.6M |
| LifeMD, Inc. (LFMD) | $194.1M | 7.4% | 9.8× | $118.7M |
| Lakeland Industries Inc. (LAKE) | $192.6M | -13.1% | — | $93.2M |
| biote Corp. (BTMD) | $192.2M | 14.1% | 7.4× | $35.3M |
| Rhythm Pharmaceuticals, Inc. (RYTM) | $189.8M | — | — | $5.93B |
| Maravai Lifesciences Holdings, Inc. (MRVI) | $185.7M | -70.4% | — | $2.42B |
| Stoke Therapeutics, Inc. (STOK) | $184.4M | -3.7% | — | $1.56B |
| Lifevantage Corp (LFVN) | $182.6M | 2.8% | 15.0× | $75.5M |
| Glass House Brands Inc. (GLAS) | $182.0M | -16.3% | — | $349.6M |
| Adaptimmune Therapeutics PLC (ADAPY) | $178.0M | -39.8% | — | $8.0M |
| Cryoport, Inc. (CYRX) | $176.2M | 44.4% | — | $842.8M |
| Heartflow, Inc. (HTFL) | $176.0M | -66.3% | — | $4.43B |
| Phathom Pharmaceuticals, Inc. (PHAT) | $175.1M | — | — | $606.8M |
| SBC Medical Group Holdings Inc (SBC) | $173.6M | 29.4% | 11.0× | $530.7M |
| Syndax Pharmaceuticals Inc (SNDX) | $172.4M | — | — | $1.15B |
| REGENXBIO Inc. (RGNX) | $170.4M | — | — | $457.1M |
| Ginkgo Bioworks Holdings, Inc. (DNA) | $170.2M | — | — | $791.9M |
| Pacific Biosciences of California, Inc. (PACB) | $160.0M | — | — | $609.2M |
| Marimed Inc. (MRMD) | $159.8M | -9.1% | — | $23.0M |
| Liquidia Corp (LQDA) | $158.3M | -43.5% | — | $3.11B |
| Heron Therapeutics, Inc. (HRTX) | $154.9M | -13.0% | — | $71.5M |
| Airsculpt Technologies, Inc. (AIRS) | $151.8M | -7.7% | — | $117.5M |
| Macrogenics Inc. (MGNX) | $149.5M | -49.9% | — | $214.7M |
| Neuronetics, Inc. (STIM) | $149.2M | -26.1% | — | $143.6M |
| Elite Pharmaceuticals Inc. (ELTP) | $148.9M | 30.1% | 6.3× | $269.3M |
| GRAIL, Inc. (GRAL) | $147.2M | — | — | $6.05B |
| Cronos Group Inc. (CRON) | $146.6M | -6.4% | — | $1.16B |
| Karyopharm Therapeutics Inc. (KPTI) | $146.1M | — | — | $8.0M |
| InfuSystem Holdings, Inc (INFU) | $143.4M | 4.6% | 34.8× | $277.2M |
| Natural Alternatives International Inc. (NAII) | $142.5M | -14.5% | — | $7.0M |
| Beam Therapeutics Inc. (BEAM) | $139.7M | -57.2% | — | $2.42B |
| Quanterix Corp (QTRX) | $138.9M | -77.1% | — | $135.7M |
| Nrc Health (NRC) | $137.4M | 8.4% | 88.0× | $466.9M |
| RxSight, Inc. (RXST) | $134.5M | -29.0% | — | $187.6M |
| Xtant Medical Holdings, Inc. (XTNT) | $133.9M | 3.7% | — | $40.2M |
| Niagen Bioscience, Inc. (NAGE) | $129.4M | 13.4% | 13.6× | $204.1M |
| Lifecore Biomedical, Inc. \de\ (LFCR) | $128.9M | -30.0% | — | $244.1M |
| Xencor Inc (XNCR) | $125.6M | -73.2% | — | $1.70B |
| Monte Rosa Therapeutics, Inc. (GLUE) | $123.7M | -31.2% | — | $863.4M |
| Atara Biotherapeutics, Inc. (ATRA) | $120.8M | 27.1% | — | $96.0M |
| Outset Medical, Inc. (OM) | $119.5M | -68.3% | — | $76.7M |
| Gyre Therapeutics, Inc. (GYRE) | $116.6M | 8.5% | — | $678.6M |
| Orasure Technologies Inc. (OSUR) | $115.0M | -59.8% | — | $270.4M |
| Agenus Inc. (AGEN) | $114.2M | -2.7% | — | $313.9M |
| ImmunityBio, Inc. (IBRX) | $113.3M | — | — | $10.60B |
| Anika Therapeutics, Inc. (ANIK) | $112.8M | -9.6% | — | $267.4M |
| Geospace Technologies Corp. (GEOS) | $110.8M | -8.8% | — | $59.9M |
| UroGen Pharma Ltd. (URGN) | $109.8M | — | — | $1.69B |
| Century Therapeutics, Inc. (IPSC) | $109.2M | -8.8% | — | $271.6M |
| Mannatech Inc. (MTEX) | $108.0M | -14.1% | — | $13.8M |
| Theravance Biopharma, Inc. (TBPH) | $107.5M | 98.5% | 16.4× | $884.2M |
| Zevra Therapeutics, Inc. (ZVRA) | $106.5M | 78.2% | 10.8× | $590.3M |
| Zymeworks Inc. (ZYME) | $106.0M | -76.6% | — | $1.80B |
| Owlet, Inc. (OWLT) | $105.7M | -37.5% | — | $129.7M |
| Sanara MedTech Inc. (SMTI) | $103.1M | -36.4% | — | $304.7M |
| Sutro Biopharma, Inc. (STRO) | $102.5M | — | — | $181.4M |
| Beta Bionics, Inc. (BBNX) | $100.3M | -73.0% | — | $910.1M |
| NeuroPace Inc (NPCE) | $100.0M | -21.5% | — | $438.7M |
| Butterfly Network, Inc. (BFLY) | $97.6M | -79.0% | — | $2.16B |
| Biolife Solutions Inc. (BLFS) | $96.2M | -4.8% | — | $1.89B |
| Kestra Medical Technologies, Ltd. (KMTS) | $95.1M | — | — | $1.62B |
| Siga Technologies Inc. (SIGA) | $94.6M | 24.6% | — | $227.8M |
| Pulmonx Corp (LUNG) | $90.5M | -59.7% | — | $79.5M |
| VASO Corp (VASO) | $89.1M | 1.8% | 14.5× | $51.0M |
| Ceribell, Inc. (CBLL) | $89.1M | -60.0% | — | $1.01B |
| Biodesix Inc. (BDSX) | $88.5M | -39.8% | — | $253.1M |
| Cytokinetics Inc. (CYTK) | $88.0M | — | — | $8.82B |
| Harvard Bioscience Inc. (HBIO) | $86.5M | -65.5% | — | $37.8M |
| LakeShore Biopharma Co., Ltd. (LSBCF) | $85.7M | -16.3% | — | — |
| Standard Biotools Inc. (LAB) | $85.3M | -87.8% | — | $258.5M |
| Delcath Systems, Inc. (DCTH) | $85.2M | 3.2% | 210.3× | $510.8M |
| 4D Molecular Therapeutics, Inc. (FDMT) | $85.2M | — | — | $682.8M |
| ARS Pharmaceuticals, Inc. (SPRY) | $84.3M | — | — | $399.8M |
| Nurix Therapeutics, Inc. (NRIX) | $84.0M | — | — | $2.73B |
| Iradimed Corp. (IRMD) | $83.8M | 26.8% | 50.2× | $1.14B |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $82.0M | -80.2% | — | $358.4M |
| Fitlife Brands, Inc. (FTLF) | $81.5M | 7.8% | 14.5× | $80.5M |
| MeiraGTx Holdings plc (MGTX) | $81.4M | — | — | $949.9M |
| ADC Therapeutics SA (ADCT) | $81.4M | — | — | $217.0M |
| TELA Bio, Inc. (TELA) | $80.3M | -48.4% | — | $44.0M |
| Eton Pharmaceuticals, Inc. (ETON) | $80.0M | -5.8% | — | $1.47B |
| Pro Dex Inc. (PDEX) | $77.5M | 17.6% | 15.1× | $194.1M |
| Sight Sciences, Inc. (SGHT) | $77.4M | -49.7% | — | $456.1M |
| Burning Rock Biotech Ltd (BNR) | $77.2M | -10.3% | — | $158.2M |
| CytomX Therapeutics, Inc. (CTMX) | $76.2M | -22.8% | — | $485.9M |
| Autolus Therapeutics plc (AUTL) | $75.4M | — | — | $449.8M |
| AbCellera Biologics Inc. (ABCL) | $75.1M | — | — | $4.09B |
| Recursion Pharmaceuticals, Inc. (RXRX) | $74.7M | — | — | $2.06B |
| Electromed, Inc. (ELMD) | $73.8M | 15.3% | 21.2× | $232.3M |
| Compugen Ltd. (CGEN) | $72.8M | 48.6% | 5.3× | $189.4M |
| Bicycle Therapeutics PLC (BCYC) | $72.6M | — | — | $245.7M |
| Assembly Biosciences, Inc. (ASMB) | $72.3M | -8.5% | — | $414.1M |
| AVITA Medical, Inc. (RCEL) | $70.9M | -68.5% | — | $403.3M |
| Viridian Therapeutics, Inc.\DE (VRDN) | $70.8M | — | — | $2.16B |
| Edap Tms SA (FOCL) | $70.5M | -41.5% | — | $195.0M |
| Black Diamond Therapeutics, Inc. (BDTX) | $70.0M | 32.0% | — | $97.4M |
| Personalis, Inc. (PSNL) | $69.6M | — | — | $1.67B |
| Rockwell Medical, Inc. (RMTI) | $69.3M | -7.7% | — | $29.9M |
| Vir Biotechnology, Inc. (VIR) | $68.6M | — | — | $1.69B |
| Intellia Therapeutics, Inc. (NTLA) | $67.7M | — | — | $1.59B |
| Kura Oncology, Inc. (KURA) | $67.5M | — | — | $862.9M |
| Spero Therapeutics, Inc. (SPRO) | $66.8M | 12.8% | 7.9× | $64.1M |
| Exagen Inc. (XGN) | $66.6M | -30.0% | — | $187.0M |
| Enanta Pharmaceuticals Inc. (ENTA) | $65.3M | — | — | $334.1M |
| Cosmos Health Inc. (COSM) | $65.3M | -29.3% | — | $38.5M |
| Concord Medical Services Holdings Ltd (CCM) | $65.0M | -20.4% | — | $16.2M |
| Nuvation Bio Inc. (NUVB) | $62.9M | — | — | $1.56B |
| Tango Therapeutics, Inc. (TNGX) | $62.4M | — | — | $4.01B |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | $61.8M | 11.0% | — | $5.6M |
| Journey Medical Corp (DERM) | $61.2M | -18.7% | — | $160.3M |
| Fortress Biotech, Inc. (FBIO) | $61.2M | 11.1% | 0.7× | $65.0M |
| Champions Oncology, Inc. (CSBR) | $59.4M | -2.0% | — | $66.9M |
| Alpha Pro Tech Ltd. (APT) | $59.1M | 6.0% | 14.7× | $58.6M |
| Aytu Biopharma, Inc. (AYTU) | $57.6M | -24.8% | — | $21.2M |
| CVRx, Inc. (CVRX) | $56.7M | -94.1% | — | $35.7M |
| 908 Devices Inc. (MASS) | $56.2M | 34.7% | — | $465.4M |
| Nektar Therapeutics (NKTR) | $55.2M | — | — | $1.29B |
| Agios Pharmaceuticals, Inc. (AGIO) | $54.0M | — | — | $1.93B |
| Q32 Bio Inc. (QTTB) | $53.7M | 55.5% | 2.4× | $223.9M |
| Invivyd, Inc. (IVVD) | $53.4M | -98.2% | — | $197.1M |
| Apyx Medical Corp (APYX) | $52.8M | -21.2% | — | $111.6M |
| Protalix BioTherapeutics, Inc. (PLX) | $52.7M | -12.5% | — | $211.1M |
| Iridex Corp. (IRIX) | $52.7M | -8.4% | — | $14.5M |
| XOMA Royalty Corp (XOMA) | $52.1M | 60.8% | 25.6× | $710.2M |
| Ocular Therapeutix, Inc. (OCUL) | $52.0M | — | — | $1.62B |
| LENSAR, Inc. (LNSR) | $51.7M | -66.4% | — | $71.3M |
| Carlsmed, Inc. (CARL) | $50.5M | -58.7% | — | $378.1M |
| Lexicon Pharmaceuticals, Inc. (LXRX) | $49.8M | — | — | $676.3M |
| Gossamer Bio, Inc. (GOSS) | $48.5M | — | — | $54.4M |
| Shoulder Innovations, Inc. (SI) | $47.3M | -85.3% | — | $377.4M |
| Protagonist Therapeutics, Inc (PTGX) | $46.0M | — | — | $9.37B |
| Septerna, Inc. (SEPN) | $46.0M | — | — | $1.79B |
| TriSalus Life Sciences, Inc. (TLSI) | $45.2M | -86.9% | — | $250.0M |
| Fennec Pharmaceuticals Inc. (FENC) | $44.6M | -21.8% | — | $362.9M |
| Aquestive Therapeutics, Inc. (AQST) | $44.5M | — | — | $603.7M |
| Cumberland Pharmaceuticals Inc. (CPIX) | $44.5M | -6.4% | — | $112.2M |
| SANUWAVE Health, Inc. (SNWV) | $44.1M | 26.8% | 23.4× | $48.3M |
| Integrated Biopharma Inc. (INBP) | $43.9M | -6.5% | — | $5.6M |
| Xilio Therapeutics, Inc. (XLO) | $43.8M | -80.1% | — | $59.6M |
| Wave Life Sciences, Inc. (WVE) | $42.7M | — | — | $616.8M |
| SS Innovations International, Inc. (SSII) | $42.5M | -28.5% | — | $529.0M |
| Coherus Oncology, Inc. (CHRS) | $42.2M | — | — | $162.2M |
| Biofrontera Inc. (BFRI) | $41.7M | -25.3% | — | $12.3M |
| KORU Medical Systems, Inc. (KRMD) | $41.1M | -6.4% | — | $137.8M |
| Myomo, Inc. (MYO) | $40.9M | -38.1% | — | $47.5M |
| Editas Medicine, Inc. (EDIT) | $40.5M | — | — | $374.7M |
| Alpha Teknova, Inc. (TKNO) | $40.5M | -42.6% | — | $474.6M |
| Voyager Therapeutics, Inc. (VYGR) | $40.4M | — | — | $123.9M |
| Sangamo Therapeutics, Inc. (SGMOQ) | $39.6M | — | — | $45.6M |
| Kymera Therapeutics, Inc. (KYMR) | $39.2M | — | — | $8.90B |
| Interpace Biosciences, Inc. (IDXG) | $38.7M | 63.5% | 1.3× | $31.1M |
| Utah Medical Products Inc. (UTMD) | $38.5M | 29.3% | 22.7× | $236.6M |
| Retractable Technologies Inc. (RVP) | $38.3M | -32.8% | — | $19.9M |
| BGM Group Ltd. (BGM) | $37.9M | -52.6% | — | $140.0M |
| Cytosorbents Corp (CTSO) | $37.1M | -22.1% | — | $9.7M |
| ClearPoint Neuro, Inc. (CLPT) | $37.0M | -69.1% | — | $281.9M |
| Lftd Partners Inc. (LIFD) | $36.9M | -67.3% | — | $1.5M |
| Sunshine Biopharma Inc. (SBFM) | $36.3M | -16.5% | — | $1.5M |
| C4 Therapeutics, Inc. (CCCC) | $35.9M | — | — | $321.1M |
| Earth Science Tech, Inc. (ETST) | $35.7M | 10.2% | 9.0× | $25.9M |
| Verrica Pharmaceuticals Inc. (VRCA) | $35.6M | -50.3% | — | $70.6M |
| X4 Pharmaceuticals, Inc (XFOR) | $35.1M | — | — | $288.5M |
| Leef Brands Inc. (LEEEF) | $34.8M | -50.7% | — | $49.8M |
| Bioharvest Sciences Inc. (BHST) | $34.5M | -32.3% | — | $39.6M |
| Precision Biosciences Inc. (DTIL) | $34.3M | — | — | $170.3M |
| Rapid Micro Biosystems, Inc. (RPID) | $33.6M | — | — | $43.8M |
| Orchestra BioMed Holdings, Inc. (OBIO) | $33.5M | — | — | $327.6M |
| Maxcyte, Inc. (MXCT) | $33.0M | — | — | $134.2M |
| C21 Investments Inc. (CWLXF) | $32.6M | -9.9% | — | $31.4M |
| Stereotaxis, Inc. (STXS) | $32.4M | -66.8% | — | $111.2M |
| electroCore, Inc. (ECOR) | $32.0M | -43.6% | — | $75.3M |
| Zomedica Corp. (ZOMDF) | $32.0M | — | — | $81.3M |
| Premier Air Charter Holdings Inc. (PREM) | $31.9M | -12.1% | — | $8.7M |
| Sonendo, Inc. (SONX) | $31.7M | -88.4% | — | $6.1M |
| Cryo Cell International Inc. (CCEL) | $31.6M | -7.7% | — | $33.5M |
| Precision Optics Corporation, Inc. (POCI) | $31.5M | -11.5% | — | $47.4M |
| EyePoint, Inc. (EYPT) | $31.4M | — | — | $263.3M |
| Verastem, Inc. (VSTM) | $30.9M | — | — | $758.9M |
| Foghorn Therapeutics Inc. (FHTX) | $30.9M | — | — | $112.2M |
| STRATA Skin Sciences, Inc. (SSKN) | $30.7M | -20.4% | — | $1,177 |
| Synergy CHC Corp. (SNYRQ) | $30.4M | -40.6% | — | $148,998 |
| Scilex Holding Co (SCLX) | $30.3M | — | — | $19.9M |
| CapForce Inc. (CFOR) | $30.2M | 78.2% | 0.5× | $34.8M |
| Bionano Genomics, Inc. (BNGO) | $28.5M | -92.6% | — | $16.1M |
| American Shared Hospital Services (AMS) | $28.1M | -5.5% | — | $8.4M |
| Immucell Corp. (ICCC) | $27.6M | -3.8% | — | $95.9M |
| Sensus Healthcare, Inc. (SRTS) | $27.5M | -28.1% | — | $48.6M |
| Cue Biopharma, Inc. (CUE) | $27.5M | -96.9% | — | $135.1M |
| Celularity Inc (CELU) | $26.6M | — | — | $42.5M |
| Entrada Therapeutics, Inc. (TRDA) | $25.4M | — | — | $170.2M |
| Metagenomi Therapeutics, Inc. (MGX) | $25.2M | — | — | $29.6M |
| Cyanotech Corp. (CYAN) | $24.2M | -13.2% | — | $5.1M |
| Alumis Inc. (ALMS) | $24.1M | — | — | $913.8M |
| Precipio, Inc. (PRPO) | $24.0M | -1.5% | — | $38.3M |
| DataMeds AI, Inc. (MEDS) | $23.3M | — | — | $8.4M |
| Baird Medical Investment Holdings Ltd (BDMD) | $22.5M | — | — | $17.7M |
| NewAmsterdam Pharma Co N.V. (NAMS) | $22.5M | — | — | $2.32B |
| DarioHealth Corp. (DRIO) | $22.4M | — | — | $50.3M |
| Lifeward Ltd. (LFWD) | $22.0M | -90.4% | — | $17.0M |
| Alector, Inc. (ALEC) | $21.0M | — | — | $205.4M |
| Charlie's Holdings, Inc. (CHUC) | $20.9M | 21.5% | — | $12.7M |
| CASI Pharmaceuticals, Inc. (CASIF) | $20.7M | — | — | $2.1M |
| Jin Medical International Ltd. (ZJYL) | $20.7M | 5.8% | 10.8× | $153.8M |
| Scynexis Inc. (SCYX) | $20.6M | -41.8% | — | $36.5M |
| Evofem Biosciences, Inc. (EVFM) | $20.2M | 1.9% | — | $927,710 |
| Spectral AI, Inc. (MDAI) | $19.6M | -38.5% | — | $48.6M |
| Sonoma Pharmaceuticals, Inc. (SNOA) | $19.5M | -16.3% | — | $5.9M |
| Sol-Gel Technologies Ltd. (SLGL) | $19.4M | -31.6% | — | $235.0M |
| LENZ Therapeutics, Inc. (LENZ) | $19.1M | — | — | $102.7M |
| Qt Imaging Holdings, Inc. (QTI) | $18.9M | — | — | $35.1M |
| Nephros Inc. (NEPH) | $18.8M | 6.4% | 24.3× | $39.6M |
| Bon Natural Life Ltd (BON) | $18.7M | -10.7% | — | $9.1M |
| OmniAb, Inc. (OABIW) | $18.7M | — | — | — |
| Marpai, Inc. (MRAI) | $18.1M | -91.5% | — | $84.0M |
| Universe Pharmaceuticals INC (UPC) | $17.9M | -20.6% | — | $20.9M |
| Birchtech Corp. (BCHT) | $17.6M | -17.2% | — | $35.2M |
| Vivos Therapeutics, Inc. (VVOS) | $17.4M | — | — | $5.0M |
| Pelthos Therapeutics Inc. (PTHS) | $16.8M | — | — | $77.1M |
| Zhengye Biotechnology Holding Ltd (ZYBT) | $16.6M | -60.0% | — | $82.0M |
| Seer, Inc. (SEER) | $16.6M | — | — | $121.3M |
| Foxo Technologies Inc. (FOXO) | $16.4M | -75.9% | — | $182,392 |
| Profound Medical Corp. (PROF) | $16.1M | — | — | $219.6M |
| uniQure N.V. (QURE) | $16.1M | — | — | $1.51B |
| Biotricity Inc. (BTCY) | $16.0M | -15.0% | — | $1.1M |
| Relay Therapeutics, Inc. (RLAY) | $15.4M | — | — | $3.92B |
| Allurion Technologies, Inc. (ALUR) | $15.2M | — | — | $309,902 |
| Vsee Health, Inc. (VSEE) | $14.6M | — | — | $1.5M |
| Opus Genetics, Inc. (IRD) | $14.2M | — | — | $336.9M |
| Arbutus Biopharma Corp (ABUS) | $14.1M | — | — | $646.8M |
| Pyxis Oncology, Inc. (PYXS) | $13.9M | — | — | $200.7M |
| CV Sciences, Inc. (CVSI) | $13.8M | -6.9% | — | $2.3M |
| Lineage Cell Therapeutics, Inc. (LCTX) | $13.6M | — | — | $247.4M |
| Hyperfine, Inc. (HYPR) | $13.6M | — | — | $90.3M |
| CapsoVision, Inc (CV) | $13.6M | — | — | $343.2M |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | $13.1M | — | — | $125.2M |
| Nano-X Imaging Ltd. (NNOX) | $13.0M | — | — | $35.6M |
| Evommune, Inc. (EVMN) | $13.0M | — | — | $187.6M |
| Escalon Medical Corp. (ESMC) | $12.7M | 31.5% | 0.6× | $1.3M |
| Emmaus Life Sciences, Inc. (EMMA) | $12.5M | -60.2% | — | $4.1M |
| Elutia Inc. (ELUT) | $12.3M | — | 0.9× | $34.2M |
| Prelude Therapeutics Inc (PRLD) | $12.1M | — | — | $310.4M |
| Cardiff Lexington Corp (CDIX) | $11.5M | -47.7% | — | $734,955 |
| Jaguar Health, Inc. (JAGX) | $11.5M | — | — | $6.9M |
| LogicMark, Inc. (LGMK) | $11.4M | -65.4% | — | $1.2M |
| Nexgel, Inc. (NXGL) | $11.4M | -26.3% | — | $2.7M |
| Caribou Biosciences, Inc. (CRBU) | $11.2M | — | — | $49.3M |
| Crescent Biopharma, Inc. (CBIO) | $10.8M | — | — | $463.6M |
| TScan Therapeutics, Inc. (TCRX) | $10.3M | — | — | $14.7M |
| Alpha Cognition Inc. (ACOG) | $10.2M | — | — | $178.4M |
| Janux Therapeutics, Inc. (JANX) | $10.0M | — | — | $1.01B |
| Zenas BioPharma, Inc. (ZBIO) | $10.0M | — | — | $1.78B |
| WORK Medical Technology Group LTD (WOK) | $9.8M | -10.9% | — | $6.2M |
| Taysha Gene Therapies, Inc. (TSHA) | $9.8M | — | — | $1.46B |
| Prothena Corp. Public Ltd. Co. (PRTA) | $9.7M | — | — | $428.7M |
| Curis Inc. (CRIS) | $9.4M | -80.3% | — | $1.2M |
| Aspira Women's Health Inc. (AWHL) | $9.2M | — | — | $10.5M |
| Roivant Sciences Ltd. (ROIV) | $8.3M | — | — | $24.22B |
| Aclaris Therapeutics, Inc. (ACRS) | $7.8M | — | — | $482.8M |
| Adagene Inc. (ADAG) | $7.7M | — | — | $138.3M |
| Whitehawk Therapeutics, Inc. (WHWK) | $7.1M | — | — | $200.7M |
| Immunome Inc. (IMNM) | $6.9M | — | — | $1.94B |
| Fate Therapeutics Inc. (FATE) | $6.6M | — | — | $230.7M |
| Kyntra Bio, Inc. (KYNB) | $6.4M | — | — | $19.6M |
| DBV Technologies S.A. (DBVT) | $5.6M | — | — | $568.8M |
| Scientific Industries Inc. (SCND) | $5.1M | -24.1% | — | $8.2M |
| NewGenIvf Group Ltd (NIVF) | $4.7M | — | — | $1.3M |
| ProPhase Labs, Inc. (PRPH) | $4.3M | — | — | $155,925 |
| CRISPR Therapeutics AG (CRSP) | $3.5M | — | — | $4.98B |
| Surrozen, Inc. (SRZN) | $3.5M | — | — | $349.0M |
| Cartesian Therapeutics, Inc. (RNAC) | $2.8M | — | — | $213.5M |
| CollPlant Biotechnologies Ltd (CLGN) | $2.4M | — | — | $7.0M |
| Lipocine Inc. (LPCN) | $2.0M | — | — | $12.9M |
| Neuphoria Therapeutics Inc. (NEUP) | $1.2M | — | — | $17.9M |
| Silence Therapeutics plc (SLN) | $559,000 | — | — | $612.8M |
| Mereo BioPharma Group plc (MREO) | $500,000 | — | — | $48.4M |
| Lite Strategy, Inc. (LITS) | $267,000 | — | — | $36.3M |
| Connect Biopharma Holdings Ltd (CNTB) | $64,000 | — | — | $57.2M |
| Amylyx Pharmaceuticals, Inc. (AMLX) | $0 | — | — | $3.47B |
| Artiva Biotherapeutics, Inc. (ARTV) | $0 | — | — | $331.0M |
| Barinthus Biotherapeutics plc. (BRNS) | $0 | — | — | $30.2M |
| Capricor Therapeutics, Inc. (CAPR) | $0 | — | — | $383.1M |
| Denali Therapeutics Inc. (DNLI) | $0 | — | — | $3.03B |
| Fulcrum Therapeutics, Inc. (FULC) | $0 | — | — | $280.3M |
| Kiora Pharmaceuticals Inc. (KPRX) | $0 | — | — | $10.6M |
| Revolution Medicines, Inc. (RVMD) | $0 | — | — | $38.14B |
| Spruce Biosciences, Inc. (SPRB) | $0 | — | — | $126.6M |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | $0 | — | — | $209.0M |
| Contineum Therapeutics, Inc. (CTNM) | — | — | — | $316.8M |
| Equillium, Inc. (EQ) | — | — | — | $83.7M |
| Maze Therapeutics, Inc. (MAZE) | — | — | — | $1.53B |
| Palvella Therapeutics, Inc. (PVLA) | — | — | — | $1.73B |
| Tvardi Therapeutics, Inc. (TVRD) | — | — | — | $13.7M |
| Veru Inc. (VERU) | — | — | — | $41.9M |
